D-MNA (doxorubicin microneedle array)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for D-MNA (doxorubicin microneedle array), covering 2022-08-17 to 2022-08-17. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) [Phase 1]